VTE prophylaxis is underutilized in medical patients in US hospitals, but the occurrence of VTE has a major clinical and economic impact.
Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data.
Understanding the perspectives of clinicians and administrators who are leaders in implementing patient-centeredness in accountable care organizations can help point the way toward implementation by others.
Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.
Patient satisfaction does not seem to be influenced by the intensity of medical resource use by their physicians.
“Healthy Steps for Older Adults,” the Pennsylvania Department of Aging’s falls prevention program, resulted in savings of $718 to $840 per person.
It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance.
Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.
The field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions. Using an online platform with an engaged patient community, we developed and psychometrically validated a new measure in just under a year.
Self-reported adherence tended to overestimate medication adherence compared with electronic monitoring. Electronic monitoring of oral hypoglycemic agents but not self-reported adherence predicted glycemic control.
Extended-duration thromboprophylaxis (>14 days) for total hip replacement/total knee replacement was associated with significantly lower risk for thromboembolic and bleeding events than short-duration thromboprophylaxis.
Healthcare providers should revisit disaster response policies to incorporate telemedicine systems to address some of the unique challenges posed by infectious disease outbreaks such as coronavirus disease 2019 (COVID-19).
Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.
Panelists discuss their excitement about the evolution of heart failure as a distinct specialty with multiple effective therapeutic options, the convergence of previously siloed medical disciplines around shared evidence-based therapies that treat root causes of multiple comorbidities, and emerging technologies like clinical decision support systems and remote patient monitoring to improve population health management and prevent hospitalizations.